Maze Therapeutics, Inc. Common Stock MAZE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$122.54M— | -$131.12M— | —— | —— | —— | ||
| $2.16M-28.6% | $2.4M-27.1% | $2.61M— | $2.83M— | $3.03M— | ||
| $20.28M+92.0% | $16.4M+70.0% | $13.18M— | $11.66M— | $10.56M— | ||
| -$121.54M— | -$111.94M— | —— | —— | —— | ||
| $588K-49.6% | $794K-30.8% | $1.37M— | $1.4M— | $1.17M— | ||
| -$164.39M-13,986% | -$170.96M-14,805% | -$68.18M— | -$1.4M— | -$1.17M— | ||
| —— | —— | —— | —— | —— | ||
| $190.32M-3.8% | $275.34M+190% | $342.01M— | $198.25M— | $197.79M— | ||
| -$95.61M— | -$7.57M— | $167.17M— | —— | —— | ||
| -$122.13M— | -$112.73M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maze Therapeutics, Inc. Common Stock generate?
- Maze Therapeutics, Inc. Common Stock (MAZE) generated -$121.5M in operating cash flow over the trailing twelve months.
- What is Maze Therapeutics, Inc. Common Stock's free cash flow?
- After $588.0K of capital expenditures, Maze Therapeutics, Inc. Common Stock's free cash flow was -$122.1M over the trailing twelve months.
- Where does Maze Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Maze Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
